David Altshuler - Feb 10, 2023 Form 4 Insider Report for VERTEX PHARMACEUTICALS INC / MA (VRTX)

Signature
/s/ Christiana Stevenson, Attorney-in-Fact
Stock symbol
VRTX
Transactions as of
Feb 10, 2023
Transactions value $
-$4,239,380
Form type
4
Date filed
2/14/2023, 03:49 PM
Previous filing
Feb 8, 2023
Next filing
Feb 16, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VRTX Common Stock Tax liability -$1.02M -3.46K -5.04% $294.33 65.2K Feb 10, 2023 Direct
transaction VRTX Common Stock Tax liability -$1.79M -5.99K -9.19% $298.26 59.2K Feb 13, 2023 Direct
transaction VRTX Common Stock Sale -$72.6K -245 -0.41% $296.44 58.9K Feb 13, 2023 Direct F1, F2, F3
transaction VRTX Common Stock Sale -$645K -2.16K -3.66% $298.47 56.8K Feb 13, 2023 Direct F1, F2, F4
transaction VRTX Common Stock Sale -$567K -1.89K -3.33% $299.36 54.9K Feb 13, 2023 Direct F1, F2, F5
transaction VRTX Common Stock Sale -$150K -500 -0.91% $300.23 54.4K Feb 13, 2023 Direct F1, F2, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transaction made pursuant to Dr. Altshuler's company approved trading plan under Rule 10b5-1.
F2 Dr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
F3 Open market sales reported on this line occurred at a weighted average price of $296.44 (range $295.84 to $296.57).
F4 Open market sales reported on this line occurred at a weighted average price of $298.47 (range $297.85 to $298.82).
F5 Open market sales reported on this line occurred at a weighted average price of $299.36 (range $298.86 to $299.83).
F6 Open market sales reported on this line occurred at a weighted average price of $300.23 (range $299.96 to $300.63).